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Epistatic Selection between Coding and Regulatory
Variation in Human Evolution and Disease
Tuuli Lappalainen,1,* Stephen B. Montgomery,1 Alexandra C. Nica,1 and Emmanouil T. Dermitzakis1,*
Interaction (nonadditive effects) between genetic variants has been highlighted as an important mechanism underlying phenotypic
variation, but the discovery of genetic interactions in humans has proved difficult. In this study, we show that the spectrum of variation
in the human genome has been shaped by modifier effects of cis-regulatory variation on the functional impact of putatively deleterious
protein-coding variants. We analyzed 1000 Genomes population-scale resequencing data from Europe (CEU [Utah residents with
Northern and Western European ancestry from the CEPH collection]) and Africa (YRI [Yoruba in Ibadan, Nigeria]) together with gene
expression data from arrays and RNA sequencing for the same samples. We observed an underrepresentation of derived putatively func-
tional coding variation on the more highly expressed regulatory haplotype, which suggests stronger purifying selection against delete-
rious coding variants that have increased penetrance because of their regulatory background. Furthermore, the frequency spectrum and
impact size distribution of common regulatory polymorphisms (eQTLs) appear to be shaped in order tominimize the selective disadvan-
tage of having deleterious coding mutations on the more highly expressed haplotype. Interestingly, eQTLs explaining common disease
GWAS signals showed an enrichment of putative epistatic effects, suggesting that some disease associationsmight arise from interactions
increasing the penetrance of rare coding variants. In conclusion, our results indicate that regulatory and coding variants often modify
the functional impact of each other. This specific type of genetic interaction is detectable from sequencing data in a genome-wide
manner, and characterizing these joint effects might help us understand functional mechanisms behind genetic associations to human
phenotypes—including both Mendelian and common disease.Genetic variants can have joint, nonadditive functional
effects,1–4 but characterizing such epistasis between
common variants in humans has proven difficult, and
undetected epistasis remains one potential reason for
the low proportion of heritability of complex traits ex-
plained by common genetic variants.5–10 In addition to
gene-gene interactions, linked loci can also have epistatic
effects,11–14 one putative mechanism being the interaction
between regulatory and coding variants of the same
gene.15,16 Potential targets of these interactions are abun-
dant: cis-regulatory variation is common17–19 and has
been estimated to affect at least 20% of protein-coding
variants within an individual in only a single tissue.16,20
In this study, we have analyzed population genetic signa-
tures of a specific but probably abundant type of epistasis:
common cis-regulatory variationmodifying thepenetrance
of rare putatively deleterious coding variants. Our results
indicate that such interactions are common and likely
contribute to genetic predisposition to complex disease.
Regulatory variation in cis might affect the penetrance
of a deleterious coding variant of the same gene through
allelic imbalance: In individuals who are heterozygous
for both a regulatory and a coding single nucleotide
variant (rSNV and cSNV, respectively), the deleterious
coding allele might have a much more severe phenotypic
outcome if it is more highly expressed than the other
allele. This might make the coding heterozygote function-
ally close to a deleterious homozygote (Figure 1A). In such
a situation, regulatory variation modifies the functional
impact—and selection coefficient—of a deleterious coding1Department of Genetic Medicine and Development, University of Geneva M
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selection coefficient of the regulatory variant even when
the change of gene expression level itself does not affect
fitness. Importantly, whether or not a rare deleterious
cSNV allele resides on the more highly or less expressed
haplotype in a gene with cis-regulatory variation is not
fully random: the probability that a new coding mutation
lands on a particular haplotype is equal to the haplotype
frequency. Altogether, these phenomena can shape the
patterns of both regulatory and coding variation, and
in this paper we show that these specific patterns are
common in the human genome.
We analyzed genetic variation discovered in the low-
coverage resequencing data of the 1000 Genomes Project
pilot 1 and 2 (release March 2010), from 60 samples of
European origin (CEU [Utah residents with ancestry from
northern and western Europe]) and 58 Yoruba individuals
from Nigeria (YRI [Yoruba in Ibadan, Nigeria]).21 The study
was approved by the institutional review boards of the
Coriell Institute for Medical Research and the University
Hospitals of Geneva. To analyze common regulatory varia-
tion, we mapped expression quantitative trait loci (eQTLs)
in cis by Spearman rank correlation by using gene expres-
sion array data from transformed lymphoblastoid cell
lines of 57 CEU and 56 YRI individuals and SNPs with
MAF > 5% and less than 1 Mb from transcription start
site, by using a permutation threshold of 0.0120. This
yielded a total of 433 eQTLs with ancestral allele informa-
tion (provided by the 1000 Genomes Consortium) in CEU
and 446 in YRI (false discovery rate 25%). We designate theedical School, Geneva, 1211-4, Switzerland
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Figure 1. Model of Epistasis between Regula-
tory and Coding Variation
Within a gene, the functional effect of a coding
variant wild-type (cSNVw) and mutant (cSNVm)
alleles can be dramatically altered by linkage
to a more highly or less expressed allele of a regu-
latory variant (rSNVþ and rSNV) (A). Com-
bining this epistatic effect with the probability
that the cSNVm is on each rSNV haplotype
gives us a model of epistasis in which the
average population fitness varies as a function
of rSNV frequency (B). In this model, epistatic
selection alters the double-heterozygote fitnesses:
w[cSNVwrSNVþ/cSNVmrSNV] ¼ 1  (1  i)hs,
and w[cSNVwrSNV/cSNVmrSNVþ] ¼ 1  [i þ
(1  i)h]s, where i denotes the magnitude of
allelic imbalance, s is the selection coefficient, and h is the dominance of the m allele. Allele frequencies are based on Hardy-Weinberg
equilibrium and additional new mutations cSNVw / cSNVm hitting the rSNVþ and rSNV haplotypes with a probability of their
frequency in rate m. Here, we have used parameters m ¼ 104, s ¼ 0.8, h ¼ 0.4, and i ¼ 0.9 or i ¼ 0. See Table S1 for details.
Figure 2. Frequency Distribution of eQTLs
The proportion of gain-of-expression eQTLs with respect to
derived allele frequency in sliding windows of 80 SNPs with an
overlap of five SNPs; this shows that the more highly expressed
alleles tend to have low frequencies (p ¼ 0.0092 in CEU and p ¼
0.026 in YRI).more highly and less expressed rSNV alleles rSNVþ and
rSNV, respectively, and classify the eQTLs in gain-of-
expression (GOE) and loss-of-expression (LOE) variants
according to the effect of the derived allele. Instead of
testing all variants against all across the genome for statis-
tical epistasis, we analyzed our data for specific patterns of
variation predicted by our model of local epistasis.
The model of epistasis predicts increased penetrance of
deleterious cSNVs when the derived cSNV allele is on the
more highly expressed haplotype in cSNV-rSNV double
heterozygotes. These cases are most likely to arise when
the rSNV has high heterozygosity, and novel putatively
deleterious coding mutations hit the rSNVþ allele—that
is, in common rSNVs with a high rSNVþ allele frequency.
These rSNVs might be under increased purifying selection
(Figure 1B). We observe a signal consistent with this in
the frequency distribution of eQTLs: GOE eQTLs had
significantly lower derived allele frequencies (DAF) than
LOE eQTLs (Figure 2; DAFGOE versus DAFLOE Mann-Whit-
ney p ¼ 0.0092 in CEU and p ¼ 0.026 in YRI), that is,
the rSNVþ alleles tend to have lower frequencies among
common regulatory variants, consistently with epistatic
selection. An alternative explanation to this pattern
would be increased gene-expression levels being more
deleterious in general but then the proportion of GOE
rSNVs should grow exponentially toward lower rSNV
frequencies. Because eQTL analysis does not capture rare
regulatory variants, we investigated whether such a pattern
can be observed by analyzing allele-specific expression
(ASE) from RNA sequencing data of 60 CEU individ-
uals.22 By using the frequency of the coding variant with
rare ASE to predict which cSNV allele is linked to the
derived allele of the unknown putative rare rSNV (Fig-
ure S1, available online), we estimated that 78 5 12%
(linear regression p ¼ 2.1 3 1010) of rare rSNVs are loss-
of-expression variants (Figure S2). Altogether, whereas
common regulatory variants with DAF 5%–50% are pre-
dominantly GOE, rare rSNVs—as well as common variants
of DAF > 50%—appear to be usually LOE. This is inconsis-
tent with the gain of expression being more deleterious in460 The American Journal of Human Genetics 89, 459–463, Septembgeneral and follows the predictions of the epistasis model
(Figure 1B).
Furthermore, we analyzed the distribution of fold
change of eQTLs (calculated as the ratio of the median
expression values of the major homozygote and the
heterozygote eQTL genotype classes), which describes the
magnitude of putative cSNVallelic imbalance and epistasis
effect in eQTL heterozygotes. We observed that especially
in CEU, common eQTLs with high frequency of the rSNV
allele tend to have higher fold changes (Figure S3). These
eQTLs are likely to have most coding mutations occurring
on the rSNV haplotype and thus benefit from epistasis:
the bigger the allelic imbalance is, the lower the pene-
trance of these cSNVs. Conversely, strong epistatic effects
in eQTLs with high rSNVþ frequencies are more likely to
be disadvantageous, which is consistent with their low
fold changes. Thus, epistatic effects appear to shape not
only the frequency spectrum of regulatory variants but
also the distribution of the magnitude of their effect.
Patterns of coding variation are also expected to be
affected by epistasis. Increased purification of deleteriouser 9, 2011
Figure 3. Signals of Epistasis in Coding
Variation
Linkage disequilibrium (D0) between eQTLs and
sSNVs or nsSNVs in CEU (A) and YRI (B). The
sSNVs were sampled to the derived allele
frequency distribution of nsSNVs, and the
numbers denote the p values for sSNV  nsSNV
comparisons. In (C), allele-specific expression
data from CEU was used to analyze how
frequently the derived allele of a coding variant
(cSNV  DER) is more highly expressed; the
plot shows medians in sliding window of 400
SNPs with an overlap of 50. The difference
between sSNVs and nsSNVs variants (p ¼
0.0035) suggests selection against increased expression of the putatively deleterious derived allele of low-frequency nsSNVs. The overall
decreasing trend is likely due to putative regulatory variants underlying the ASE effect being more often loss-of-expression variants (see
Figures S1 and S2).
Figure 4. Properties of Disease-Associated eQTLs
Percentage of disease-associated eQTLs of control eQTLs with
respect to derived allele frequency in sliding windows of 0.05 (A)
suggests an enrichment of disease-associated eQTLs in the parts
of the frequency spectrum in which epistasis might increase the
penetrance of rare coding variants. The vertical lines denote the
average percentages. (B) The eQTL alleles linked to the disease
risk allele are shown;þ and denoting the more highly or less ex-
pressed alleles.cSNV alleles from the more highly expressed haplotype
might lead to different distribution of putatively delete-
rious cSNVs and neutral cSNVs on the regulatory haplo-
types. To investigate this, we compared nonsynonymous
and synonymous SNVs (nsSNVs and sSNVs, respectively),
expecting the former to show stronger signs of interaction
with rSNVs. First, epistasis would favor some haplotype
combinations over others, which is expected to increase
the overall linkage disequilibrium (LD). Indeed, LD be-
tween eQTLs and nsSNVs was stronger than for sSNVs
(Figures 3A and 3B and Figure S6; Mann-Whitney p values
for CEU and YRI are 0.012 and 0.008 for D0, and 0.002 and
0.078, for r2, respectively). This is consistent with our
previous results based on RNA sequencing data from 60
CEU individuals.20 Second, we investigated whether this
LD pattern is likely caused by underrepresentation of puta-
tively deleterious coding alleles on the more highly ex-
pressed haplotype. Analysis of allele-specific expression
(ASE) data from the same RNA sequencing dataset22
showed that a larger proportion of nsSNVs than sSNVs
showed decreased expression of the derived allele
(Figure 3C; p ¼ 0.0035 for overall sSNV-nsSNV difference
according to a linear regression model, and Fisher’s exact
test p ¼ 0.046 for cSNVs with DAF < 0.15, see also Figures
S1 and S2). This analysis is unlikely to be biased because of
nsSNVs being putatively more often causal regulatory
variants themselves because such an autoregulatory mech-
anism would be unlikely to cause allelic imbalance, and we
have observed that ASE occurrence in sSNVs and nsSNVs
overall is almost equal.20 Furthermore, in haplotype-
phased eQTL data (from the 1000 Genomes July 2010
release) in CEU, the more highly expressed haplotype
carried significantly fewer derived alleles of nsSNVs than
of sSNVs (Fisher’s exact test p ¼ 2 3 104, Table S2). These
results suggest that epistatic selection leads to deficiency
of deleterious coding variation on the more highly ex-
pressed regulatory haplotype. Additionally, we investi-
gated whether epistasis can also affect the total number
of coding variants in genes with regulatory variation, and
we observed that the number of cSNVs was decreased in
eQTL genes (Mann-Whitney p < 2.2 3 1016 in CEU,
p ¼ 6.4 3 103 in YRI; Figure S3) and, importantly, wasThe Americandecreased even more in CEU when the rSNVþ allele
was common; this suggests that epistasis might expose
coding variants to selection and lead to increased purifying
selection.
Finally, we asked whether epistatic effects might play
a role in genetic predisposition to complex disease, with
an enrichment of deleterious alleles on themore highly ex-
pressed haplotype potentially increasing disease risk. To
this end, we used the Regulatory Trait Concordance
score23 to define 98 disease-associated eQTLs in which
the eQTL is likely to tag the same variant as a GWAS SNP
(from NHGRI catalog24 accessed April 12, 2010) and
compared them to 934 control eQTLs. This analysis was
based on a dataset of 75 European individuals with geno-
types imputed to HapMap2 and array expression data
from fibroblasts, T cells, and LCLs.25 Figure 4A shows an
enrichment of disease eQTLs in high frequencies of the
rSNVþ allele, when random coding mutations are more
likely to hit this haplotype and possibly have increased
penetrance. This trend is opposite to that observed for
eQTLs overall—suggesting that the variants not following
the general pattern putatively optimized by evolution areJournal of Human Genetics 89, 459–463, September 9, 2011 461
more likely to contribute to disease. Furthermore, the
disease risk allele is more often the eQTLþ allele or linked
to it (21/30 cases with available data, c2 test p ¼ 0.023,
Figure 4B)—although this pattern alone (but not the
frequency pattern in Figure 4A) could be caused by the
increased expression level itself being detrimental. Alto-
gether, these results suggest that a proportion of disease
associations due to regulatory variants might arise from
the dysfunction of the rSNVþ allele because it increases
the penetrance of linked cSNVs. However, we did not
observe significant differences in the patterns of coding
variation in the 60 CEU individuals between genes with
disease-associated and control eQTLs (Figure S6). Future
studies with case-control material will, we hope, clarify
whether increased disease risk sometimes arises neither
from changed gene-expression levels alone nor from an
enrichment of rare cSNVs per se but from their interaction.
Table S3 gives a list of disease-associated eQTLs with a high
frequency of the more highly expressed haplotype; these
would be the best candidates for searching for the epistatic
effect.
In conclusion, our study illustrates how epistasis
between coding and cis-regulatory variants has shaped
the spectrum of genetic variation in the human genome.
The straightforward principle of interaction recapitulates
many of the phenomena observed in the data and opens
ground for future research of the role of epistasis in, for
example, tissue specificity25 and genetic associations to
complex disease.6,7,11 In future studies, more refined
models characterizing the population genetic dynamics
of epistasis will, we hope, shed light on differences
between populations, genetic load caused by epistasis,
and evolutionary equilibria.26 Additionally, this type of
epistasis might contribute to varying penetrance of
Mendelian disorders,27 in which the penetrance of a rare
disease-causing allele could be modified by the individual’s
genotype of a common regulatory variant of that gene. In
this study we focused on interactions between common
rSNVs and rare cSNVs, but the accumulating genomic
and RNA sequencing data will enable analysis of modi-
fying effects that rare regulatory variation might have on
both rare and common coding variation.
Altogether, our results show that the functional effects of
regulatory variation often extend beyond gene-expression
levels and that the impact of rare coding variants is fre-
quently modified by regulatory variation. This might
have important practical implications for understanding
functional effects of genetic variants—and this specific
type of genetic interaction can be relatively easily detected
from sequencing data in a genome-wide manner, as out-
lined in this study. Phenotypic associations to regulatory
variants have only rarely led to characterization of expres-
sion differences underlying the phenotype,18 and our
results suggest that a proportion of these signals might
actually be driven not by expression change itself but
by increased penetrance of deleterious coding variants.
Additionally, considerable effort is being directed to the462 The American Journal of Human Genetics 89, 459–463, Septembdiscovery of loss-of-function coding variants from genome
or exome sequencing data. Thus far, these data have rarely
been complemented with RNA sequencing data from rele-
vant tissues to understand how the predicted functional
effect is actually manifested in the downstream pathways
of the cell and in the phenotype. In the future, the inte-
grated analysis of regulatory and coding variants will be
important in characterizing the genetic sources of pheno-
typic variation in humans.Supplemental Data
Supplemental Data include six figures and three tables and can be
found with this article online at http://www.cell.com/AJHG/.Acknowledgments
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